US20110046452A1 - Wireless device and system for monitoring physiologic parameters - Google Patents
Wireless device and system for monitoring physiologic parameters Download PDFInfo
- Publication number
- US20110046452A1 US20110046452A1 US12/704,685 US70468510A US2011046452A1 US 20110046452 A1 US20110046452 A1 US 20110046452A1 US 70468510 A US70468510 A US 70468510A US 2011046452 A1 US2011046452 A1 US 2011046452A1
- Authority
- US
- United States
- Prior art keywords
- implant
- sensor
- diseases
- miniature
- physiologic parameters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6879—Means for maintaining contact with the body
- A61B5/6882—Anchoring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
- A61N1/37223—Circuits for electromagnetic coupling
Definitions
- This invention relates generally to medical devices monitoring blood pressure and other physiologic parameters.
- a number of different physiologic parameters are strong candidates for continuous monitoring, such as blood pressure or flow, cardiovascular pressure, intracranial pressure, intraocular pressure, glucose levels, etc.
- Wireless sensors in particular are highly desirable for biologic applications because the transcutaneous passage of wires (or other communication “tethers”) risks both infection to the patient and physical injury or device damage if the communication link experiences excessive pulling force.
- a large number of proposed schemes for non-medical wireless communication rely on magnetic coupling between an electrical coil in an implanted device and a separate, external “readout” coil.
- One method of wireless communication well-known to those knowledgeable in the art is that of the LC tank resonator.
- a series-parallel connection of a capacitor and inductor has a specific resonant frequency ideally expressed as 1/ ⁇ square root over (LC) ⁇ , which can be measured from the impedance of the circuit. If one element of the inductor-capacitor pair varies with some physical parameter (e.g. pressure), while the other element remains at a known value, the physical parameter may be determined from the resonant frequency.
- the capacitance may be back-calculated from the resonant frequency.
- the sensed pressure may then be deduced from the capacitance by means of a calibrated pressure-capacitance transfer function.
- the impedance of the LC tank may be measured directly or it may also be determined indirectly from the impedance of a separate readout coil that is magnetically coupled to the internal coil.
- a separate readout coil that is magnetically coupled to the internal coil.
- the latter case is most useful for biologic applications in that the sensing device may be subcutaneously implanted, while the readout coil may be located external to the body, but in a location that allows magnetic coupling between the implant and readout coil. It is possible for the readout coil (or coils) to simultaneously excite the implant resonator and sense the impedance reflected back to the readout coil. Consequently, this architecture has the substantial advantage of requiring no internal power source, which greatly improves its prospects for long-term implantation (e.g. decades to a human lifetime).
- Frenkel U.S. Pat. No. 5,005,577 describes an implantable lens for monitoring intraocular pressure. Such a device would be advantageous for monitoring elevated eye pressures (as is usually the case for glaucoma patients); however, the requirement that the eye's crystalline lens be replaced will likely limit the general acceptance of this device.
- CVF Chronic Heart Failure
- Porat U.S. Pat. No. 6,277,078
- Eigler U.S. Pat. No. 6,328,699
- Carney U.S. Pat. No. 5,368,040
- What is described is a general scheme of monitoring the heart. The existence of a method to construct a sensor with sufficient size, long-term fidelity, stability, telemetry range, and biocompatibility is noticeably absent in each case, being instead simply assumed.
- the disclosed devices require a complex electromechanical assembly with many dissimilar materials, which will result in significant temperature- and aging-induced drift over time. Such assemblies may also be too large for many desirable applications, including intraocular pressure monitoring and/or pediatric applications. Finally, complex assembly processes will make such devices prohibitively expensive to manufacture for widespread use.
- microfabricated sensors have also been proposed.
- One such device is taught by Darrow (U.S. Pat. No. 6,201,980).
- Others are reported in the literature (see, e.g. Park, et al., Jpn. J. Appl. Phys., 37 (1998), pp. 7124-7128; Puers, et al., J. Micromech. Microeng. 10 (2000), pp. 124-129; Harpster et al., Proc. 14 th IEEE Intl Conf. Microelectromech. Sys. (2001), pp. 553-557).
- a self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external reader device.
- the implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible.
- the circuit, sensor, and antenna for telemetry are packaged together in a small volume and sealed hermetically to the biologic environment.
- the larger reader unit remains outside the body but proximal to the implant for minimizing communication distance.
- FIG. 1 is a side view of a miniature sensor module according to a preferred embodiment of the present invention.
- FIG. 2 is a top, side, and perspective view of a flexible substrate to rigid substrate self aligning connection illustrating a preferred arrangement of electrical leads within a substrate cavity.
- FIG. 3 is a block diagram of a magnetic telemetry based physiologic monitoring system according to a preferred embodiment of the present invention.
- FIG. 4 is a perspective view of a sensor implant incorporating a screw anchoring mechanism.
- FIG. 5 is a side view of a sensor implanted in the atrial septum according to a preferred embodiment of the present invention.
- the preferred communication scheme for the present invention is based on magnetic telemetry.
- an implant 17 lays passive and without any internal means to power itself.
- the reader 19 is brought into a suitable range to the implant 17 .
- the reader 18 then creates an RF (Radio Frequency) magnetic field large enough to induce sufficient voltage across the implant coil 9 .
- the implant circuit 8 may rectify the alternating waveform to create a direct voltage, which analog and/or digital circuitry may use as a power supply.
- the implant 17 can be considered alert and, in the preferred embodiment, also ready for commands from the reader 18 .
- a number of techniques may be used to convert the sensor output into a form suitable for transmission back to the reader 18 .
- a capacitive pressure sensor 2 and sigma delta conversion or capacitance to frequency conversion of the sensor output may be easily used.
- Capacitive sensors are preferred due to the small power requirements for electronics when reading capacitance values.
- Many pressure sensors are based on piezoresistive effects and, while suitable for some applications, do suffer in this application due to the higher power levels needed for readout.
- Sigma delta converters are preferred due to the tolerance of noisy supply voltages and manufacturing variations.
- modulation schemes are available for transmitting data via magnetic coupling.
- the preferred schemes include but are not limited to amplitude modulation, frequency modulation, frequency shift keying, phase shift keying, and also spread spectrum techniques.
- the preferred modulation scheme may be determined by the specifications of an individual application, and is not intended to be limited under this invention.
- the implant 17 may communicate back to the reader 18 the signal containing pressure information. It is understood that the reader 18 may transmit either a continuous level of RF power to supply the implant's needed energy, or it may pulse the power allowing temporary storage in a battery or capacitor device. Similarly, the implant 17 of FIG. 3 may signal back to the reader 18 at any interval in time, delayed or instantaneous, during reader RF transmission or alternately in the absence of reader transmission.
- the implant 17 may include a single coil antenna 9 for both reception and transmission, or it may include two antennas, one each for transmission 21 and reception 9 .
- the preferred embodiment of the invention is based on a small inner package, preferably of glass and silicon, that can be fit with a number of shell options for various implantation methods.
- the cross-section in FIG. 1 illustrates a glass and silicon package for the miniature implant 17 according to a preferred embodiment of the invention.
- the implant 17 includes a substrate 1 , a miniature sensor 2 , and electronics 3 (both coil 9 and integrated circuit die 8 included in electronics).
- a secondary and optional substrate 4 may be used for attaching the various electronic components to each other and to sensor connections.
- An alternative preferred method is to use a cylindrical shaped package, made from silicon, glass, ceramic, metal, plastic, or any combination thereof which houses the coil and the electronic components.
- the miniature sensor 2 can either be fabricated separately and is attached to the cylindrical package or may be directly fabricated onto the substrate 1 .
- the shell may be a separately fabricated piece into which the sensor 2 is placed; or it may be directly fabricated on the sensor submodule (or some portion thereof); or it may be integral to the inner package, being only defined by a change in material.
- the purpose of the shell is to simplify fabrication by allowing different processes, process flows, materials, and/or structures to be used for the subassembly (e.g. MEMS technologies) and the shell (e.g. machining and/or molding of plastics, glass, metals, rubbers, polymers, etc.)
- the material of the sensor submodule may be compatible with the environment, in which case a shell is not required and the submodule becomes the completed sensor.
- the miniature sensor 2 can be any suitable miniature sensor adapted to detect and/or monitor various physiological parameters.
- the sensor 2 can comprise a pressure sensor, a temperature sensor, a flow sensor, a velocity sensor, or a sensor adapted to measure specific chemistries such as gas content (e.g., O 2 and CO 2 ) and glucose levels.
- gas content e.g., O 2 and CO 2
- glucose levels e.g., glucose levels
- chemistries e.g., O 2 and CO 2
- Various specific examples of these types of miniature sensors are known to those skilled in the art, and any one or more of these suitable sensors can be utilized in the sensor module of the present invention. While the specific type of sensor(s) 2 chosen will depend on the application of the implantable system, the sensor(s) 2 should be of a sufficiently small size in order to facilitate placement within a catheter for delivery and implantation.
- the bottom substrate 1 defines a cavity 6 in which the electronics 3 may be placed.
- the rigid substrate cavity walls enclose the electronics 3 on five of the six possible sides.
- at least part of the sensor 2 is disposed on the top side of the bottom substrate 1 .
- Connections 16 to the sensor 2 may be made in a substrate recess 5 (recess is optional for increased clearance, and connection may alternately be co-planar with or above the plane of the substrate) adjoining the larger cavity 6 , or through alternate lead transfer techniques in the substrate cavity 6 .
- a top substrate 7 is attached to the bottom substrate 1 to form a hermetic seal around the sensor and electronics.
- the physically interacting parts of the sensor are formed in the top substrate 7 and complete the sensor structure after subsequent processing steps after bonding.
- the two substrates 1 and 17 may be made of materials such as glass and silicon that are preferably anodically bonded together and provide excellent bond mechanical properties. Alternate methods of attachment include: fusion, frit, solder, laser welds, other welding, compression, thermal, thermal compression, eutectic, glue.
- the electronic circuitry is connected together via a rigid or flexible substrate, which may be either the bottom substrate 1 or a separate substrate 4 .
- the connection between the integrated circuit die 8 and substrate 1 or 4 is preferably made with flip-chip process to avoid the more fragile wire bonds.
- the circuit die 8 may include ASIC (Application Specific Integrated Circuits), capacitors, or diodes.
- the leads from the inductor coil 9 may fold over the substrate 4 or preformed for soldering to the substrate 4 with a preferably biocompatible solder such as gold-tin or silver-tin.
- the flexible substrate 4 may also extend to the connections for the sensor 2 , where the connection may be made with a number of methods such as silver epoxy, laser welding, solder, or other.
- FIG. 2 Aligning the flexible substrate 4 to the bottom substrate recess 5 is shown in FIG. 2 .
- a preferred structure to accommodate manufacturing tolerances matches a tapered recess 5 in the bottom substrate 1 to a wedge fixture 15 of the flex circuit 4 , ensuring that electrical contacts 16 are properly aligned. As the wedge 15 is inserted into the recess 5 , the electrical contacts 16 are forced to align themselves to avoid faulty connections. Furthermore, any variance in the width of the wedges 15 and recess 5 will be accommodated by a small variation in the final, lateral depth of insertion of the flex circuit 4 .
- FIG. 3 illustrates a block diagram for the electronics 3 according to the present invention.
- the electronic circuit may consist of a receiving inductor coil 9 , rectification circuitry 10 , signal conditioning circuitry 11 , and signal transmission circuitry 12 .
- the coil conductor may be wound around a ferrite core to enhance magnetic properties, deposited on a flat rigid or flexible substrate, and formed into a long/skinny or short/wide cylindrical solenoid.
- the conductor is preferably made at least in part with a metal of high conductivity such as copper, silver, gold.
- the coil may alternately be fabricated on substrates 1 , 4 , or 8 (or any combination thereof) of FIG. 1 . Methods of fabrication include sputtering, electroplating, lift-off, screen printing, and/or other suitable methods known to those skilled in the art.
- the rectification circuitry 10 outputs a constant voltage level for the other electronics from an alternating voltage input. Efficient realizations of such circuitry are standard electronic techniques and may include full bridge diode rectifiers in the preferred embodiment. This rectification circuitry may include a capacitor for transient energy storage to reduce the noise ripple on the output supply voltage. This circuitry may be implemented on the same integrated circuit die with other electronics.
- the signal conditioning circuit 11 processes an output signal from the sensor 2 and prepares it for transmission to an external receiving and/or analyzing device. For example, many pressure sensors output a capacitance signal that may be digitized for radio frequency (RF) transmission. Accordingly, the signal conditioning circuit places the output signal of the sensor into an appropriate form.
- RF radio frequency
- Many different signal conditioning circuits are known to those skilled in the art. Capacitance to frequency conversion, sigma delta or other analog to digital conversion techniques are all possible conditioning circuits that may be used in a preferred embodiment.
- the signal transmission circuitry transmits the encoded signal from the signal conditioning circuitry for reception by an external reader. Magnetic telemetry is again used for this communication, as the transmission circuitry generates an alternating electromagnetic field that propagates to the reader. Either the same coil 9 is used for signal reception and for transmission, or alternately a second coil 21 is dedicated for transmission only.
- the preferred embodiment has limited protrusion of volume into the blood stream, as both shape and size are factors in thrombogenesis.
- Another shell may be overmolded or preformed to house the glass/silicon module, and the outer shell contains the necessary apparatus for anchoring the implant.
- the outer shell may be formed with existing plastic injection technologies suitable for medical implantation.
- a coating, preferably of silicone, parylene and/or polymers provides a non-thrombogenic exterior for the biologic environment.
- the implant may be located in various places depending on the blood pressure measurement of interest. For chronic heart failure the end-diastolic pressure may be of most importance, and therefore the left chambers of the heart or immediately attaching vessels may be preferred locations. Because the number of implants is not practically limited by the technology, multiple locations for blood pressure and/or other physiologic parameter measurements are easily established, including all chambers of the heart, major arteries and appendages. In the preferred embodiment, embedding the module in an area that does not significantly impede blood flow can minimize the thrombogenic effect of flow turbulence caused by this volume.
- the implant may be modified with anchoring methods found on devices already used for implantation.
- Devices such as septal occluders, pacemaker leads, left atrial appendage occluders, etc. may be used as carriers for the current invention.
- Pacemaker leads have a well-established history for implantation methods, and similar techniques are possible for the current invention.
- a screw 13 or barb may be used to attach the implant to a heart or vessel wall.
- a screw may be molded into the device shell 26 , and screwed into the ventricle wall so that the screw buries below the wall surface.
- the package may have mesh 25 attached to the device to promote tissue growth and anchoring.
- a second package option can be attached with a metal tine or barb placed with a catheter. These devices work well in trabeculated areas of the heart, and therefore are used often for implanting pacing leads in the right ventricle. Clips or expanding probes may also be used, both of which would penetrate the heart or vessel wall slightly.
- Atrial septum defects a septal occluder
- An umbrella structure 14 may be folded inside a catheter for delivery and then expanded for implantation.
- the present invention may be anchored to the septum with similar techniques, as shown in FIG. 5 .
- An important aspect of this preferred embodiment is that the majority of the implantable sensing device is located in the right side of the heart, with minimum protrusion in the left side of the heart. This embodiment will greatly reduce the thrombogenicity.
- the readout 18 includes an inductor 19 for communicating with and powering the implant 17 via magnetic telemetry. Also included is signal reception 24 , signal processing 23 , and transmission circuitry 22 for data analysis and subsequent communication.
- FIG. 3 illustrates the system diagram and the blocks of the reader. There are many techniques for construction of the reader coil and processing electronics known to those skilled in the art.
- the reader may interface to a display, computer, or other data logging device 20 .
- the described system could be augmented with various actuation functions.
- the implant device would augmented with any of various actuators, including but not limited to: thermal generators; voltage or current sources, probes, or electrodes; drug delivery pumps, valves, or meters; microtools for localized surgical procedures; radiation-emitting sources; defibrillators; muscle stimulators; pacing stimulators.
Abstract
A system for monitoring blood pressure and other physiologic parameters is provided. The system is designed such that it can be delivered to the patient with ease and minimal invasion. The system contains at least one self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external readout device. The implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible. The circuit, sensor, and antenna for telemetry are packaged together and sealed hermetically to the biologic environment. The larger readout unit remains outside the body but proximal to the implant for minimizing communication distance.
Description
- This is a division patent application of co-pending U.S. patent application Ser. No. 10/677,674.
- This invention relates generally to medical devices monitoring blood pressure and other physiologic parameters.
- A number of different physiologic parameters are strong candidates for continuous monitoring, such as blood pressure or flow, cardiovascular pressure, intracranial pressure, intraocular pressure, glucose levels, etc. Wireless sensors in particular are highly desirable for biologic applications because the transcutaneous passage of wires (or other communication “tethers”) risks both infection to the patient and physical injury or device damage if the communication link experiences excessive pulling force.
- A large number of proposed schemes for non-medical wireless communication rely on magnetic coupling between an electrical coil in an implanted device and a separate, external “readout” coil. One method of wireless communication well-known to those knowledgeable in the art is that of the LC tank resonator. A series-parallel connection of a capacitor and inductor has a specific resonant frequency ideally expressed as 1/√{square root over (LC)}, which can be measured from the impedance of the circuit. If one element of the inductor-capacitor pair varies with some physical parameter (e.g. pressure), while the other element remains at a known value, the physical parameter may be determined from the resonant frequency. For example, if the capacitor corresponds to a capacitive pressure sensor, the capacitance may be back-calculated from the resonant frequency. The sensed pressure may then be deduced from the capacitance by means of a calibrated pressure-capacitance transfer function.
- The impedance of the LC tank may be measured directly or it may also be determined indirectly from the impedance of a separate readout coil that is magnetically coupled to the internal coil. The latter case is most useful for biologic applications in that the sensing device may be subcutaneously implanted, while the readout coil may be located external to the body, but in a location that allows magnetic coupling between the implant and readout coil. It is possible for the readout coil (or coils) to simultaneously excite the implant resonator and sense the impedance reflected back to the readout coil. Consequently, this architecture has the substantial advantage of requiring no internal power source, which greatly improves its prospects for long-term implantation (e.g. decades to a human lifetime).
- Such devices have been proposed in various forms for many applications. Chubbuck (U.S. Pat. No. 4,026,276), Bullara (U.S. Pat. No. 4,127,110), and Dunphy (U.S. Pat. No. 3,958,558) disclose various devices initially intended for hydrocephalus applications (but also amenable to others) that use LC resonant circuits. The '276, '110, and '558 patents, although feasible, do not take advantage of recent advances in silicon (or similar) microfabrication technologies. Kensey (U.S. Pat. No. 6,015,386) discloses an implantable device for measuring blood pressure in a vessel of the wrist. This device must be “assembled” around the vessel being monitored such that it fully encompasses the vessel, which may not be feasible in many cases. In another application, Frenkel (U.S. Pat. No. 5,005,577) describes an implantable lens for monitoring intraocular pressure. Such a device would be advantageous for monitoring elevated eye pressures (as is usually the case for glaucoma patients); however, the requirement that the eye's crystalline lens be replaced will likely limit the general acceptance of this device.
- In addition to the aforementioned applications that specify LC resonant circuits, other applications would also benefit greatly from such wireless sensing. Han, et al. (U.S. Pat. No. 6,268,161) describe a wireless implantable glucose (or other chemical) sensor that employs a pressure sensor as an intermediate transducer (in conjunction with a hydrogel) from the chemical into the electrical domain.
- For example, the treatment of cardiovascular diseases such as Chronic Heart Failure (CHF) can be greatly improved through continuous and/or intermittent monitoring of various pressures and/or flows in the heart and associated vasculature. Porat (U.S. Pat. No. 6,277,078), Eigler (U.S. Pat. No. 6,328,699), and Carney (U.S. Pat. No. 5,368,040) each teach different modes of monitoring heart performance using wireless implantable sensors. In every case, however, what is described is a general scheme of monitoring the heart. The existence of a method to construct a sensor with sufficient size, long-term fidelity, stability, telemetry range, and biocompatibility is noticeably absent in each case, being instead simply assumed. Eigler, et al., come closest to describing a specific device structure although they disregard the baseline and sensitivity drift issues that must be addressed in a long-term implant. Applications for wireless sensors located in a stent (e.g., U.S. Pat. No. 6,053,873 by Govari) have also been taught, although little acknowledgment is made of the difficulty in fabricating a pressure sensor with telemetry means sufficiently small to incorporate into a stent.
- Closed-loop drug delivery systems, such as that of Feingold (U.S. Pat. No. 4,871,351) have likewise been taught. As with others, Feingold overlooks the difficulty in fabricating sensors that meet the performance requirements needed for long-term implantation.
- In nearly all of the aforementioned cases, the disclosed devices require a complex electromechanical assembly with many dissimilar materials, which will result in significant temperature- and aging-induced drift over time. Such assemblies may also be too large for many desirable applications, including intraocular pressure monitoring and/or pediatric applications. Finally, complex assembly processes will make such devices prohibitively expensive to manufacture for widespread use.
- As an alternative to conventionally fabricated devices, microfabricated sensors have also been proposed. One such device is taught by Darrow (U.S. Pat. No. 6,201,980). Others are reported in the literature (see, e.g. Park, et al., Jpn. J. Appl. Phys., 37 (1998), pp. 7124-7128; Puers, et al., J. Micromech. Microeng. 10 (2000), pp. 124-129; Harpster et al., Proc. 14th IEEE Intl Conf. Microelectromech. Sys. (2001), pp. 553-557).
- Past efforts to develop wireless sensors have typically been limited to implant-readout separation distances of 1-2 cm, rendering them impractical for implantation much below the cutaneous layer. This would eliminate from consideration applications such as heart ventricle pressure monitoring or intracranial pressure monitoring, which require separation distances in the range of 5-10 cm. In the present state-of-the-art, several factors have contributed to this limitation, including: 1) signal attenuation due to intervening tissue, 2) suboptimal design for magnetic coupling efficiency; and 3) high internal energy losses in the implanted device.
- It is an object of this invention to provide a system for chronic monitoring of blood pressure and other physiological parameters.
- It is also an object of this invention to provide a system including an implantable device for monitoring blood pressure and other physiologic parameters that is delivered to the patient with ease and minimal invasion.
- It is also an object of this invention to provide a method for delivering an implantable device for monitoring blood pressure and other physiologic parameters that is delivered to the patient with ease and minimal invasion.
- The above objects are achieved by providing at least a self contained implantable sensing device consisting of a sensor, an electrical circuit for signal conditioning and magnetic telemetry, a biocompatible outer surface and seal, an anchoring method, and an external reader device. The implant is small in size so that it may be delivered to the desired location and implanted using a catheter, although direct surgical implantation is also possible. The circuit, sensor, and antenna for telemetry are packaged together in a small volume and sealed hermetically to the biologic environment. The larger reader unit remains outside the body but proximal to the implant for minimizing communication distance.
-
FIG. 1 is a side view of a miniature sensor module according to a preferred embodiment of the present invention. -
FIG. 2 is a top, side, and perspective view of a flexible substrate to rigid substrate self aligning connection illustrating a preferred arrangement of electrical leads within a substrate cavity. -
FIG. 3 is a block diagram of a magnetic telemetry based physiologic monitoring system according to a preferred embodiment of the present invention. -
FIG. 4 is a perspective view of a sensor implant incorporating a screw anchoring mechanism. -
FIG. 5 is a side view of a sensor implanted in the atrial septum according to a preferred embodiment of the present invention. - The following description of preferred embodiments and methods provides examples of the present invention. The embodiments discussed herein are merely exemplary in nature, and are not intended to limit the scope of the invention in any manner. Rather, the description of these preferred embodiments and methods serves to enable a person of ordinary skill in the relevant art to make, use and perform the present invention.
- The preferred communication scheme for the present invention, shown in
FIG. 3 , is based on magnetic telemetry. Without anexternal reader 18 present, animplant 17 lays passive and without any internal means to power itself. When a pressure reading is desired, thereader 19 is brought into a suitable range to theimplant 17. Thereader 18 then creates an RF (Radio Frequency) magnetic field large enough to induce sufficient voltage across theimplant coil 9. When such a sufficient voltage exists across theimplant coil 9, theimplant circuit 8 may rectify the alternating waveform to create a direct voltage, which analog and/or digital circuitry may use as a power supply. At this point theimplant 17 can be considered alert and, in the preferred embodiment, also ready for commands from thereader 18. - Once the direct voltage in the
implant 17 has been established for the circuit operation, a number of techniques may be used to convert the sensor output into a form suitable for transmission back to thereader 18. In the preferred embodiment, acapacitive pressure sensor 2 and sigma delta conversion or capacitance to frequency conversion of the sensor output may be easily used. Capacitive sensors are preferred due to the small power requirements for electronics when reading capacitance values. Many pressure sensors are based on piezoresistive effects and, while suitable for some applications, do suffer in this application due to the higher power levels needed for readout. Sigma delta converters are preferred due to the tolerance of noisy supply voltages and manufacturing variations. - As those skilled in magnetic telemetry are aware, a number of modulation schemes are available for transmitting data via magnetic coupling. The preferred schemes include but are not limited to amplitude modulation, frequency modulation, frequency shift keying, phase shift keying, and also spread spectrum techniques. The preferred modulation scheme may be determined by the specifications of an individual application, and is not intended to be limited under this invention.
- In addition to the many available modulation techniques are the many technologies developed that allow the
implant 17 to communicate back to thereader 18 the signal containing pressure information. It is understood that thereader 18 may transmit either a continuous level of RF power to supply the implant's needed energy, or it may pulse the power allowing temporary storage in a battery or capacitor device. Similarly, theimplant 17 ofFIG. 3 may signal back to thereader 18 at any interval in time, delayed or instantaneous, during reader RF transmission or alternately in the absence of reader transmission. Theimplant 17 may include asingle coil antenna 9 for both reception and transmission, or it may include two antennas, one each fortransmission 21 andreception 9. - The preferred embodiment of the invention is based on a small inner package, preferably of glass and silicon, that can be fit with a number of shell options for various implantation methods. The cross-section in
FIG. 1 illustrates a glass and silicon package for theminiature implant 17 according to a preferred embodiment of the invention. As illustrated inFIG. 1 , theimplant 17 includes asubstrate 1, aminiature sensor 2, and electronics 3 (bothcoil 9 and integrated circuit die 8 included in electronics). A secondary andoptional substrate 4 may be used for attaching the various electronic components to each other and to sensor connections. An alternative preferred method is to use a cylindrical shaped package, made from silicon, glass, ceramic, metal, plastic, or any combination thereof which houses the coil and the electronic components. Theminiature sensor 2 can either be fabricated separately and is attached to the cylindrical package or may be directly fabricated onto thesubstrate 1. Note that the shell may be a separately fabricated piece into which thesensor 2 is placed; or it may be directly fabricated on the sensor submodule (or some portion thereof); or it may be integral to the inner package, being only defined by a change in material. - The purpose of the shell is to simplify fabrication by allowing different processes, process flows, materials, and/or structures to be used for the subassembly (e.g. MEMS technologies) and the shell (e.g. machining and/or molding of plastics, glass, metals, rubbers, polymers, etc.) In some applications, the material of the sensor submodule may be compatible with the environment, in which case a shell is not required and the submodule becomes the completed sensor.
- The
miniature sensor 2 can be any suitable miniature sensor adapted to detect and/or monitor various physiological parameters. For example, thesensor 2 can comprise a pressure sensor, a temperature sensor, a flow sensor, a velocity sensor, or a sensor adapted to measure specific chemistries such as gas content (e.g., O2 and CO2) and glucose levels. Various specific examples of these types of miniature sensors are known to those skilled in the art, and any one or more of these suitable sensors can be utilized in the sensor module of the present invention. While the specific type of sensor(s) 2 chosen will depend on the application of the implantable system, the sensor(s) 2 should be of a sufficiently small size in order to facilitate placement within a catheter for delivery and implantation. - In the preferred embodiment of the
implant 17 shown inFIG. 1 , thebottom substrate 1 defines acavity 6 in which theelectronics 3 may be placed. With cubic geometry, the rigid substrate cavity walls enclose theelectronics 3 on five of the six possible sides. Also in a preferred embodiment, at least part of thesensor 2 is disposed on the top side of thebottom substrate 1.Connections 16 to thesensor 2 may be made in a substrate recess 5 (recess is optional for increased clearance, and connection may alternately be co-planar with or above the plane of the substrate) adjoining thelarger cavity 6, or through alternate lead transfer techniques in thesubstrate cavity 6. - A
top substrate 7 is attached to thebottom substrate 1 to form a hermetic seal around the sensor and electronics. In a preferred embodiment, the physically interacting parts of the sensor are formed in thetop substrate 7 and complete the sensor structure after subsequent processing steps after bonding. The twosubstrates - In a preferred arrangement, the electronic circuitry is connected together via a rigid or flexible substrate, which may be either the
bottom substrate 1 or aseparate substrate 4. The connection between the integrated circuit die 8 andsubstrate inductor coil 9 may fold over thesubstrate 4 or preformed for soldering to thesubstrate 4 with a preferably biocompatible solder such as gold-tin or silver-tin. Theflexible substrate 4 may also extend to the connections for thesensor 2, where the connection may be made with a number of methods such as silver epoxy, laser welding, solder, or other. - Aligning the
flexible substrate 4 to thebottom substrate recess 5 is shown inFIG. 2 . A preferred structure to accommodate manufacturing tolerances matches atapered recess 5 in thebottom substrate 1 to awedge fixture 15 of theflex circuit 4, ensuring thatelectrical contacts 16 are properly aligned. As thewedge 15 is inserted into therecess 5, theelectrical contacts 16 are forced to align themselves to avoid faulty connections. Furthermore, any variance in the width of thewedges 15 andrecess 5 will be accommodated by a small variation in the final, lateral depth of insertion of theflex circuit 4. -
FIG. 3 illustrates a block diagram for theelectronics 3 according to the present invention. The electronic circuit may consist of a receivinginductor coil 9,rectification circuitry 10,signal conditioning circuitry 11, andsignal transmission circuitry 12. - A large number of possible geometries and structures are available for
receiver coil 9 and known to those skilled in the art. The coil conductor may be wound around a ferrite core to enhance magnetic properties, deposited on a flat rigid or flexible substrate, and formed into a long/skinny or short/wide cylindrical solenoid. The conductor is preferably made at least in part with a metal of high conductivity such as copper, silver, gold. The coil may alternately be fabricated onsubstrates FIG. 1 . Methods of fabrication include sputtering, electroplating, lift-off, screen printing, and/or other suitable methods known to those skilled in the art. - The
rectification circuitry 10 outputs a constant voltage level for the other electronics from an alternating voltage input. Efficient realizations of such circuitry are standard electronic techniques and may include full bridge diode rectifiers in the preferred embodiment. This rectification circuitry may include a capacitor for transient energy storage to reduce the noise ripple on the output supply voltage. This circuitry may be implemented on the same integrated circuit die with other electronics. - The
signal conditioning circuit 11 processes an output signal from thesensor 2 and prepares it for transmission to an external receiving and/or analyzing device. For example, many pressure sensors output a capacitance signal that may be digitized for radio frequency (RF) transmission. Accordingly, the signal conditioning circuit places the output signal of the sensor into an appropriate form. Many different signal conditioning circuits are known to those skilled in the art. Capacitance to frequency conversion, sigma delta or other analog to digital conversion techniques are all possible conditioning circuits that may be used in a preferred embodiment. - The signal transmission circuitry transmits the encoded signal from the signal conditioning circuitry for reception by an external reader. Magnetic telemetry is again used for this communication, as the transmission circuitry generates an alternating electromagnetic field that propagates to the reader. Either the
same coil 9 is used for signal reception and for transmission, or alternately asecond coil 21 is dedicated for transmission only. - To limit the risk of thrombogenesis, the preferred embodiment has limited protrusion of volume into the blood stream, as both shape and size are factors in thrombogenesis. Another shell may be overmolded or preformed to house the glass/silicon module, and the outer shell contains the necessary apparatus for anchoring the implant. In a preferred embodiment, the outer shell may be formed with existing plastic injection technologies suitable for medical implantation. A coating, preferably of silicone, parylene and/or polymers provides a non-thrombogenic exterior for the biologic environment.
- The implant may be located in various places depending on the blood pressure measurement of interest. For chronic heart failure the end-diastolic pressure may be of most importance, and therefore the left chambers of the heart or immediately attaching vessels may be preferred locations. Because the number of implants is not practically limited by the technology, multiple locations for blood pressure and/or other physiologic parameter measurements are easily established, including all chambers of the heart, major arteries and appendages. In the preferred embodiment, embedding the module in an area that does not significantly impede blood flow can minimize the thrombogenic effect of flow turbulence caused by this volume.
- The implant may be modified with anchoring methods found on devices already used for implantation. Devices such as septal occluders, pacemaker leads, left atrial appendage occluders, etc. may be used as carriers for the current invention.
- Pacemaker leads have a well-established history for implantation methods, and similar techniques are possible for the current invention. A
screw 13 or barb may be used to attach the implant to a heart or vessel wall. In the first package option shown inFIG. 4 , a screw may be molded into thedevice shell 26, and screwed into the ventricle wall so that the screw buries below the wall surface. In addition, the package may havemesh 25 attached to the device to promote tissue growth and anchoring. - A second package option can be attached with a metal tine or barb placed with a catheter. These devices work well in trabeculated areas of the heart, and therefore are used often for implanting pacing leads in the right ventricle. Clips or expanding probes may also be used, both of which would penetrate the heart or vessel wall slightly.
- Devices have been made and approved by the FDA to occlude atrial septum defects (a septal occluder) and other vascular holes. An umbrella structure 14 may be folded inside a catheter for delivery and then expanded for implantation. In a preferred embodiment, the present invention may be anchored to the septum with similar techniques, as shown in
FIG. 5 . An important aspect of this preferred embodiment is that the majority of the implantable sensing device is located in the right side of the heart, with minimum protrusion in the left side of the heart. This embodiment will greatly reduce the thrombogenicity. - The
readout 18 includes aninductor 19 for communicating with and powering theimplant 17 via magnetic telemetry. Also included issignal reception 24,signal processing 23, andtransmission circuitry 22 for data analysis and subsequent communication.FIG. 3 illustrates the system diagram and the blocks of the reader. There are many techniques for construction of the reader coil and processing electronics known to those skilled in the art. The reader may interface to a display, computer, or otherdata logging device 20. - Note that in addition to sensing physiologic parameters, the described system could be augmented with various actuation functions. In such case, the implant device would augmented with any of various actuators, including but not limited to: thermal generators; voltage or current sources, probes, or electrodes; drug delivery pumps, valves, or meters; microtools for localized surgical procedures; radiation-emitting sources; defibrillators; muscle stimulators; pacing stimulators.
- The foregoing disclosure includes the best mode devised by the inventors for practicing the invention. It is apparent, however, that several variations in the apparatuses and methods of the present invention may be conceivable by one skilled in the art. Inasmuch as the foregoing disclosure is intended to enable one skilled in the pertinent art to practice the instant invention, it should not be construed to be limited thereby, but should be construed to include such aforementioned variations.
Claims (7)
1. A miniature implant for measuring physiologic parameters for medical applications, comprising:
Implantable self-contained sensor module for measuring physiologic parameters wherein the module:
senses physiologic parameters with a sensor;
receives operating power from a magnetic field with an inductor coil;
conditions a sensor signal;
transmits a conditioned sensor signal to an external signal detection system via magnetic telemetry;
outer shell to house sensor module fit with anchoring mechanism for implantation.
2. The miniature implant of claim 1 wherein the implant is delivered and implanted with a catheter.
3. The miniature implant of claim 1 wherein the anchoring mechanism passes through a septum wall and opens on either side of a septal wall, clamping the implant to the wall.
4. The miniature implant of claim 1 wherein the anchoring mechanism is a helical screw.
5. The miniature implant of claim 1 wherein the anchoring mechanism is a tine that expands and catches on a trabeculated area of the heart.
6. The implant of claim 1 wherein said module is used for applications including but not limited to one or more of the following
cardiovascular diseases,
congestive heart failure,
congenital heart diseases,
diseases related to intracranial pressure,
abdominal aortic aneurysm,
intraocular pressure for eye related diseases including but not limited to glaucoma,
urinary diseases,
gastrointestinal diseases.
7. The implant of claim 1 wherein the sensor measures one or more of the following
parameters
pressure,
temperature,
flow,
blood composition,
blood gas content,
chemical composition,
acceleration,
vibration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/704,685 US20110046452A1 (en) | 2002-10-03 | 2010-02-12 | Wireless device and system for monitoring physiologic parameters |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41553802P | 2002-10-03 | 2002-10-03 | |
US41553702P | 2002-10-03 | 2002-10-03 | |
US41640702P | 2002-10-07 | 2002-10-07 | |
US41640902P | 2002-10-07 | 2002-10-07 | |
US41640802P | 2002-10-07 | 2002-10-07 | |
US41640602P | 2002-10-07 | 2002-10-07 | |
US10/677,674 US7686762B1 (en) | 2002-10-03 | 2003-10-02 | Wireless device and system for monitoring physiologic parameters |
US12/704,685 US20110046452A1 (en) | 2002-10-03 | 2010-02-12 | Wireless device and system for monitoring physiologic parameters |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/677,674 Division US7686762B1 (en) | 2002-10-03 | 2003-10-02 | Wireless device and system for monitoring physiologic parameters |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110046452A1 true US20110046452A1 (en) | 2011-02-24 |
Family
ID=57132902
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/677,674 Active - Reinstated 2026-12-16 US7686762B1 (en) | 2002-10-03 | 2003-10-02 | Wireless device and system for monitoring physiologic parameters |
US12/399,131 Active 2029-08-21 US9498130B2 (en) | 2002-10-03 | 2009-03-06 | Wireless device and system for monitoring physiologic parameters |
US12/704,685 Abandoned US20110046452A1 (en) | 2002-10-03 | 2010-02-12 | Wireless device and system for monitoring physiologic parameters |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/677,674 Active - Reinstated 2026-12-16 US7686762B1 (en) | 2002-10-03 | 2003-10-02 | Wireless device and system for monitoring physiologic parameters |
US12/399,131 Active 2029-08-21 US9498130B2 (en) | 2002-10-03 | 2009-03-06 | Wireless device and system for monitoring physiologic parameters |
Country Status (1)
Country | Link |
---|---|
US (3) | US7686762B1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2725969A1 (en) * | 2011-06-30 | 2014-05-07 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
WO2014144070A1 (en) * | 2013-03-15 | 2014-09-18 | Hunter William L | Stent monitoring assembly and method of use thereof |
RU2613086C2 (en) * | 2015-05-08 | 2017-03-15 | Общество с ограниченной ответственностью "М-ЛАЙН" (ООО "М-ЛАЙН") | Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity |
US10022054B2 (en) | 2011-06-08 | 2018-07-17 | Integrated Sensing Systems, Inc. | Implantable wireless sensor systems |
CN108778108A (en) * | 2016-03-23 | 2018-11-09 | 皇家飞利浦有限公司 | Blood pressure monitor |
US10206592B2 (en) | 2012-09-14 | 2019-02-19 | Endotronix, Inc. | Pressure sensor, anchor, delivery system and method |
US10226218B2 (en) | 2011-06-30 | 2019-03-12 | Endotronix, Inc. | Pressure sensing implant |
IT201800003693A1 (en) * | 2018-03-16 | 2019-09-16 | St Microelectronics Srl | STRESS SENSOR, STRUCTURAL INTEGRITY MONITORING SYSTEM FOR CONSTRUCTION AND MANUFACTURING PROCESS OF A STRESS SENSOR |
US10499855B2 (en) | 2012-12-21 | 2019-12-10 | Canary Medical Inc. | Stent graft monitoring assembly and method of use thereof |
US10524694B2 (en) | 2014-06-25 | 2020-01-07 | Canaray Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US10638955B2 (en) | 2011-06-30 | 2020-05-05 | Endotronix, Inc. | Pressure sensing implant |
US10687704B2 (en) | 2009-12-30 | 2020-06-23 | The University Of Kentucky Research Foundation | System, device, and method for determination of intraocular pressure |
US11103146B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Wireless sensor for measuring pressure |
US11896365B2 (en) | 2011-06-30 | 2024-02-13 | Endotronix, Inc. | MEMS device for an implant assembly |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050165317A1 (en) * | 2003-11-04 | 2005-07-28 | Turner Nicholas M. | Medical devices |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
CN103259027A (en) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | Pharma-informatics system |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
CN105468895A (en) | 2006-05-02 | 2016-04-06 | 普罗透斯数字保健公司 | Patient customized therapeutic regimens |
US8054140B2 (en) | 2006-10-17 | 2011-11-08 | Proteus Biomedical, Inc. | Low voltage oscillator for medical devices |
SG175681A1 (en) | 2006-10-25 | 2011-11-28 | Proteus Biomedical Inc | Controlled activation ingestible identifier |
EP2069004A4 (en) | 2006-11-20 | 2014-07-09 | Proteus Digital Health Inc | Active signal processing personal health signal receivers |
CN101686800A (en) | 2007-02-01 | 2010-03-31 | 普罗秋斯生物医学公司 | Ingestible event marker systems |
CA2676280C (en) | 2007-02-14 | 2018-05-22 | Proteus Biomedical, Inc. | In-body power source having high surface area electrode |
EP2124725A1 (en) | 2007-03-09 | 2009-12-02 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
EP2063771A1 (en) | 2007-03-09 | 2009-06-03 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
US8154389B2 (en) | 2007-03-15 | 2012-04-10 | Endotronix, Inc. | Wireless sensor reader |
US10003862B2 (en) | 2007-03-15 | 2018-06-19 | Endotronix, Inc. | Wireless sensor reader |
US8115618B2 (en) | 2007-05-24 | 2012-02-14 | Proteus Biomedical, Inc. | RFID antenna for in-body device |
WO2009031150A2 (en) * | 2007-09-05 | 2009-03-12 | Sensible Medical Innovations Ltd. | Method and system for monitoring thoracic tissue fluid |
WO2010100649A1 (en) | 2009-03-04 | 2010-09-10 | Sensible Medical Innovations Ltd. | Methods and systems for monitoring intrabody tissues |
EP2192946B1 (en) | 2007-09-25 | 2022-09-14 | Otsuka Pharmaceutical Co., Ltd. | In-body device with virtual dipole signal amplification |
US20090221885A1 (en) * | 2008-02-25 | 2009-09-03 | Cardiac Pacemakers, Inc. | Optical Window Assembly for Implantable Medical Device |
SG188839A1 (en) | 2008-03-05 | 2013-04-30 | Proteus Digital Health Inc | Multi-mode communication ingestible event markers and systems, and methods of using the same |
AU2009268827B2 (en) | 2008-07-08 | 2013-10-24 | Proteus Digital Health, Inc. | Ingestible event marker data framework |
US8540633B2 (en) | 2008-08-13 | 2013-09-24 | Proteus Digital Health, Inc. | Identifier circuits for generating unique identifiable indicators and techniques for producing same |
US10667715B2 (en) | 2008-08-20 | 2020-06-02 | Sensible Medical Innovations Ltd. | Methods and devices of cardiac tissue monitoring and analysis |
AU2009313879B2 (en) | 2008-11-13 | 2011-10-20 | Proteus Digital Health, Inc. | Ingestible therapy activator system and method |
CN102271578B (en) | 2008-12-11 | 2013-12-04 | 普罗秋斯数字健康公司 | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
TWI424832B (en) | 2008-12-15 | 2014-02-01 | Proteus Digital Health Inc | Body-associated receiver and method |
CA2750158A1 (en) | 2009-01-06 | 2010-07-15 | Proteus Biomedical, Inc. | Ingestion-related biofeedback and personalized medical therapy method and system |
KR20110104079A (en) | 2009-01-06 | 2011-09-21 | 프로테우스 바이오메디컬, 인코포레이티드 | Pharmaceutical dosages delivery system |
US8072764B2 (en) * | 2009-03-09 | 2011-12-06 | Apple Inc. | Multi-part substrate assemblies for low profile portable electronic devices |
GB2480965B (en) | 2009-03-25 | 2014-10-08 | Proteus Digital Health Inc | Probablistic pharmacokinetic and pharmacodynamic modeling |
EP3906845A1 (en) | 2009-04-28 | 2021-11-10 | Otsuka Pharmaceutical Co., Ltd. | Highly reliable ingestible event markers |
EP2432458A4 (en) | 2009-05-12 | 2014-02-12 | Proteus Digital Health Inc | Ingestible event markers comprising an ingestible component |
US8907682B2 (en) * | 2009-07-30 | 2014-12-09 | Sensible Medical Innovations Ltd. | System and method for calibration of measurements of interacted EM signals in real time |
US8558563B2 (en) | 2009-08-21 | 2013-10-15 | Proteus Digital Health, Inc. | Apparatus and method for measuring biochemical parameters |
TWI517050B (en) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | System for supply chain management |
UA109424C2 (en) | 2009-12-02 | 2015-08-25 | PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS | |
US8715300B2 (en) | 2009-12-05 | 2014-05-06 | Integrated Sensing Systems, Inc. | Delivery system, method, and anchor for medical implant placement |
JP5841951B2 (en) | 2010-02-01 | 2016-01-13 | プロテウス デジタル ヘルス, インコーポレイテッド | Data collection system |
SG184494A1 (en) | 2010-04-07 | 2012-11-29 | Proteus Biomedical Inc | Miniature ingestible device |
TWI557672B (en) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device |
JP2014504902A (en) | 2010-11-22 | 2014-02-27 | プロテウス デジタル ヘルス, インコーポレイテッド | Ingestible device with medicinal product |
US8928671B2 (en) | 2010-11-24 | 2015-01-06 | Fujitsu Limited | Recording and analyzing data on a 3D avatar |
US20120130203A1 (en) * | 2010-11-24 | 2012-05-24 | Fujitsu Limited | Inductively-Powered Ring-Based Sensor |
US8641610B2 (en) | 2010-12-20 | 2014-02-04 | Covidien Lp | Access assembly with translating lumens |
US8602983B2 (en) | 2010-12-20 | 2013-12-10 | Covidien Lp | Access assembly having undercut structure |
US8696557B2 (en) | 2010-12-21 | 2014-04-15 | Covidien Lp | Access assembly including inflatable seal member |
US8868794B2 (en) | 2010-12-27 | 2014-10-21 | Medtronic, Inc. | Application limitations for a medical communication module and host device |
JP2014514032A (en) | 2011-03-11 | 2014-06-19 | プロテウス デジタル ヘルス, インコーポレイテッド | Wearable personal body-related devices with various physical configurations |
US9649113B2 (en) | 2011-04-27 | 2017-05-16 | Covidien Lp | Device for monitoring physiological parameters in vivo |
US20230371842A1 (en) * | 2011-06-30 | 2023-11-23 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
US9011551B2 (en) | 2011-07-11 | 2015-04-21 | The Regents Of The University Of Michigan | Multimodality left atrial appendage occlusion device |
ES2666857T3 (en) | 2011-07-18 | 2018-05-08 | Mor-Research Applications Ltd. | A device to adjust intraocular pressure |
EP2734973A4 (en) | 2011-07-21 | 2015-07-01 | Proteus Digital Health Inc | Mobile communication device, system, and method |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
AU2013293234B2 (en) | 2012-07-23 | 2017-08-31 | Otsuka Pharmaceutical Co., Ltd. | Techniques for manufacturing ingestible event markers comprising an ingestible component |
WO2014062674A1 (en) | 2012-10-18 | 2014-04-24 | Proteus Digital Health, Inc. | Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
US11149123B2 (en) | 2013-01-29 | 2021-10-19 | Otsuka Pharmaceutical Co., Ltd. | Highly-swellable polymeric films and compositions comprising the same |
JP6498177B2 (en) | 2013-03-15 | 2019-04-10 | プロテウス デジタル ヘルス, インコーポレイテッド | Identity authentication system and method |
US11744481B2 (en) | 2013-03-15 | 2023-09-05 | Otsuka Pharmaceutical Co., Ltd. | System, apparatus and methods for data collection and assessing outcomes |
US10175376B2 (en) | 2013-03-15 | 2019-01-08 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
US10420583B2 (en) | 2013-05-22 | 2019-09-24 | Covidien Lp | Methods and apparatus for controlling surgical instruments using a port assembly |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
CA2924815C (en) | 2013-09-20 | 2017-06-20 | Proteus Digital Health, Inc. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
WO2015044722A1 (en) | 2013-09-24 | 2015-04-02 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
WO2016022713A1 (en) * | 2014-08-05 | 2016-02-11 | Purvis Rick | Telemetry arrangements for implantable devices |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
US10478067B2 (en) | 2016-05-09 | 2019-11-19 | Integrated Sensing Systems, Inc. | Implantable sensing devices and anchoring methods therefor |
EP3463044A4 (en) | 2016-05-31 | 2020-07-29 | Qura, Inc. | Implantable intraocular pressure sensors and methods of use |
KR102215238B1 (en) | 2016-07-22 | 2021-02-22 | 프로테우스 디지털 헬스, 인코포레이티드 | Electromagnetic sensing and detection of ingestible event markers |
WO2018081337A1 (en) | 2016-10-26 | 2018-05-03 | Proteus Digital Health, Inc. | Methods for manufacturing capsules with ingestible event markers |
AU2017371223B2 (en) | 2016-12-09 | 2023-04-27 | Zenflow, Inc. | Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra |
US11615257B2 (en) | 2017-02-24 | 2023-03-28 | Endotronix, Inc. | Method for communicating with implant devices |
EP3585252A1 (en) | 2017-02-24 | 2020-01-01 | Endotronix, Inc. | Wireless sensor reader assembly |
AU2018254569B2 (en) | 2017-04-20 | 2022-05-12 | Endotronix, Inc. | Anchoring system for a catheter delivered device |
US11766550B2 (en) | 2017-05-21 | 2023-09-26 | Veris Health, Inc. | Implantable medication infusion port with physiologic monitoring |
CN108968976B (en) | 2017-05-31 | 2022-09-13 | 心脏起搏器股份公司 | Implantable medical device with chemical sensor |
EP3654835A1 (en) | 2017-07-19 | 2020-05-27 | Endotronix, Inc. | Physiological monitoring system |
CN109381195B (en) | 2017-08-10 | 2023-01-10 | 心脏起搏器股份公司 | Systems and methods including electrolyte sensor fusion |
CN109419515B (en) | 2017-08-23 | 2023-03-24 | 心脏起搏器股份公司 | Implantable chemical sensor with staged activation |
EP3479757A1 (en) | 2017-11-07 | 2019-05-08 | Integrated Sensing Systems, Inc. | Implantable sensing devices and anchoring methods therefor |
CN109864746B (en) | 2017-12-01 | 2023-09-29 | 心脏起搏器股份公司 | Multimode analyte sensor for medical devices |
CN109864747B (en) | 2017-12-05 | 2023-08-25 | 心脏起搏器股份公司 | Multimode analyte sensor optoelectronic interface |
US11291391B2 (en) * | 2017-12-11 | 2022-04-05 | Microoptx Inc. | Implantable ocular glucose sensor devices and methods |
KR101884226B1 (en) * | 2017-12-29 | 2018-08-02 | 신종환 | Bio-signal detection apparatus using bone graft substitute |
BR112020024640A2 (en) | 2018-06-03 | 2021-03-02 | Olga Bokeriya | systems, methods and devices for the treatment of bradyarrhythmias, tachyarrhythmias and heart failure |
US11096582B2 (en) | 2018-11-20 | 2021-08-24 | Veris Health Inc. | Vascular access devices, systems, and methods for monitoring patient health |
CN114786629A (en) | 2019-11-19 | 2022-07-22 | 真复灵公司 | Systems, devices, and methods for accurate deployment and imaging of implants in the prostatic urethra |
JP2023526673A (en) | 2020-05-19 | 2023-06-22 | コラヴィ メディカル,インコーポレーテッド | Injectable hemodynamic monitoring device, system and method |
US11883028B2 (en) | 2021-09-08 | 2024-01-30 | Covidien Lp | Systems and methods for post-operative anastomotic leak detection |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3958558A (en) * | 1974-09-16 | 1976-05-25 | Huntington Institute Of Applied Medical Research | Implantable pressure transducer |
US4026276A (en) * | 1976-04-05 | 1977-05-31 | The Johns Hopkins University | Intracranial pressure monitor |
US4127110A (en) * | 1976-05-24 | 1978-11-28 | Huntington Institute Of Applied Medical Research | Implantable pressure transducer |
US4871351A (en) * | 1984-09-28 | 1989-10-03 | Vladimir Feingold | Implantable medication infusion system |
US5005577A (en) * | 1988-08-23 | 1991-04-09 | Frenkel Ronald E P | Intraocular lens pressure monitoring device |
US5368040A (en) * | 1993-08-02 | 1994-11-29 | Medtronic, Inc. | Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor |
US6015386A (en) * | 1998-05-07 | 2000-01-18 | Bpm Devices, Inc. | System including an implantable device and methods of use for determining blood pressure and other blood parameters of a living being |
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6268161B1 (en) * | 1997-09-30 | 2001-07-31 | M-Biotech, Inc. | Biosensor |
US6277078B1 (en) * | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US6328699B1 (en) * | 2000-01-11 | 2001-12-11 | Cedars-Sinai Medical Center | Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure |
US6409674B1 (en) * | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6970742B2 (en) * | 2000-01-11 | 2005-11-29 | Savacor, Inc. | Method for detecting, diagnosing, and treating cardiovascular disease |
US20070032734A1 (en) * | 2002-10-03 | 2007-02-08 | Integrated Sensing Systems, Inc. | Method for monitoring a physiologic parameter of patients with congestive heart failure |
US7211048B1 (en) * | 2002-10-07 | 2007-05-01 | Integrated Sensing Systems, Inc. | System for monitoring conduit obstruction |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5067491A (en) * | 1989-12-08 | 1991-11-26 | Becton, Dickinson And Company | Barrier coating on blood contacting devices |
US5833603A (en) * | 1996-03-13 | 1998-11-10 | Lipomatrix, Inc. | Implantable biosensing transponder |
DE19638813C1 (en) * | 1996-09-20 | 1998-03-05 | Sican F & E Gmbh Sibet | Measuring device for medical applications with an intracorporeally usable sensor element and method for its production |
US6111520A (en) | 1997-04-18 | 2000-08-29 | Georgia Tech Research Corp. | System and method for the wireless sensing of physical properties |
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
US6432050B1 (en) | 1997-12-30 | 2002-08-13 | Remon Medical Technologies Ltd. | Implantable acoustic bio-sensing system and method |
US6486588B2 (en) | 1997-12-30 | 2002-11-26 | Remon Medical Technologies Ltd | Acoustic biosensor for monitoring physiological conditions in a body implantation site |
US6475170B1 (en) | 1997-12-30 | 2002-11-05 | Remon Medical Technologies Ltd | Acoustic biosensor for monitoring physiological conditions in a body implantation site |
US6278379B1 (en) | 1998-04-02 | 2001-08-21 | Georgia Tech Research Corporation | System, method, and sensors for sensing physical properties |
US6589180B2 (en) * | 2001-06-20 | 2003-07-08 | Bae Systems Information And Electronic Systems Integration, Inc | Acoustical array with multilayer substrate integrated circuits |
US7147604B1 (en) * | 2002-08-07 | 2006-12-12 | Cardiomems, Inc. | High Q factor sensor |
-
2003
- 2003-10-02 US US10/677,674 patent/US7686762B1/en active Active - Reinstated
-
2009
- 2009-03-06 US US12/399,131 patent/US9498130B2/en active Active
-
2010
- 2010-02-12 US US12/704,685 patent/US20110046452A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3958558A (en) * | 1974-09-16 | 1976-05-25 | Huntington Institute Of Applied Medical Research | Implantable pressure transducer |
US4026276A (en) * | 1976-04-05 | 1977-05-31 | The Johns Hopkins University | Intracranial pressure monitor |
US4127110A (en) * | 1976-05-24 | 1978-11-28 | Huntington Institute Of Applied Medical Research | Implantable pressure transducer |
US4871351A (en) * | 1984-09-28 | 1989-10-03 | Vladimir Feingold | Implantable medication infusion system |
US5005577A (en) * | 1988-08-23 | 1991-04-09 | Frenkel Ronald E P | Intraocular lens pressure monitoring device |
US5368040A (en) * | 1993-08-02 | 1994-11-29 | Medtronic, Inc. | Apparatus and method for determining a plurality of hemodynamic variables from a single, chroniclaly implanted absolute pressure sensor |
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
US6268161B1 (en) * | 1997-09-30 | 2001-07-31 | M-Biotech, Inc. | Biosensor |
US6015386A (en) * | 1998-05-07 | 2000-01-18 | Bpm Devices, Inc. | System including an implantable device and methods of use for determining blood pressure and other blood parameters of a living being |
US6409674B1 (en) * | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6201980B1 (en) * | 1998-10-05 | 2001-03-13 | The Regents Of The University Of California | Implantable medical sensor system |
US6277078B1 (en) * | 1999-11-19 | 2001-08-21 | Remon Medical Technologies, Ltd. | System and method for monitoring a parameter associated with the performance of a heart |
US6328699B1 (en) * | 2000-01-11 | 2001-12-11 | Cedars-Sinai Medical Center | Permanently implantable system and method for detecting, diagnosing and treating congestive heart failure |
US6970742B2 (en) * | 2000-01-11 | 2005-11-29 | Savacor, Inc. | Method for detecting, diagnosing, and treating cardiovascular disease |
US20070032734A1 (en) * | 2002-10-03 | 2007-02-08 | Integrated Sensing Systems, Inc. | Method for monitoring a physiologic parameter of patients with congestive heart failure |
US7211048B1 (en) * | 2002-10-07 | 2007-05-01 | Integrated Sensing Systems, Inc. | System for monitoring conduit obstruction |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11684276B2 (en) | 2005-06-21 | 2023-06-27 | Tc1, Llc | Implantable wireless pressure sensor |
US11179048B2 (en) | 2005-06-21 | 2021-11-23 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | System for deploying an implant assembly in a vessel |
US11103147B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Method and system for determining a lumen pressure |
US11103146B2 (en) | 2005-06-21 | 2021-08-31 | St. Jude Medical Luxembourg Holdings Ii S.A.R.L. (“Sjm Lux 11”) | Wireless sensor for measuring pressure |
US11890082B2 (en) | 2005-06-21 | 2024-02-06 | Tc1 Llc | System and method for calculating a lumen pressure utilizing sensor calibration parameters |
US10687704B2 (en) | 2009-12-30 | 2020-06-23 | The University Of Kentucky Research Foundation | System, device, and method for determination of intraocular pressure |
US10022054B2 (en) | 2011-06-08 | 2018-07-17 | Integrated Sensing Systems, Inc. | Implantable wireless sensor systems |
US10433764B2 (en) | 2011-06-30 | 2019-10-08 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
US10226218B2 (en) | 2011-06-30 | 2019-03-12 | Endotronix, Inc. | Pressure sensing implant |
EP3345536A1 (en) * | 2011-06-30 | 2018-07-11 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
US11547320B2 (en) | 2011-06-30 | 2023-01-10 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
JP2017192733A (en) * | 2011-06-30 | 2017-10-26 | エンドトロニックス インコーポレイテッド | Wireless circuitry |
CN103857325A (en) * | 2011-06-30 | 2014-06-11 | 内电子有限公司 | Implantable sensor enclosure with thin sidewalls |
US9867552B2 (en) | 2011-06-30 | 2018-01-16 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
AU2012275126B2 (en) * | 2011-06-30 | 2017-04-13 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
US11707230B2 (en) | 2011-06-30 | 2023-07-25 | Endotronix, Inc. | Pressure sensing implant |
EP2725969A1 (en) * | 2011-06-30 | 2014-05-07 | Endotronix, Inc. | Implantable sensor enclosure with thin sidewalls |
US11589773B2 (en) | 2011-06-30 | 2023-02-28 | Endotronix, Inc. | MEMS device for an implant assembly |
US10638955B2 (en) | 2011-06-30 | 2020-05-05 | Endotronix, Inc. | Pressure sensing implant |
EP2725969A4 (en) * | 2011-06-30 | 2015-02-18 | Endotronix Inc | Implantable sensor enclosure with thin sidewalls |
US11896365B2 (en) | 2011-06-30 | 2024-02-13 | Endotronix, Inc. | MEMS device for an implant assembly |
JP2014523320A (en) * | 2011-06-30 | 2014-09-11 | エンドトロニックス インコーポレイテッド | Implantable sensor enclosure with thin sidewalls |
US10206592B2 (en) | 2012-09-14 | 2019-02-19 | Endotronix, Inc. | Pressure sensor, anchor, delivery system and method |
US10499855B2 (en) | 2012-12-21 | 2019-12-10 | Canary Medical Inc. | Stent graft monitoring assembly and method of use thereof |
US11445978B2 (en) | 2012-12-21 | 2022-09-20 | Canary Medical Switzerland Ag | Stent graft monitoring assembly and method of use thereof |
WO2014144070A1 (en) * | 2013-03-15 | 2014-09-18 | Hunter William L | Stent monitoring assembly and method of use thereof |
US11389079B2 (en) | 2014-06-25 | 2022-07-19 | Canary Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US10524694B2 (en) | 2014-06-25 | 2020-01-07 | Canaray Medical Inc. | Devices, systems and methods for using and monitoring tubes in body passageways |
US11911141B2 (en) | 2014-06-25 | 2024-02-27 | Canary Medical Switzerland Ag | Devices, systems and methods for using and monitoring tubes in body passageways |
RU2613086C2 (en) * | 2015-05-08 | 2017-03-15 | Общество с ограниченной ответственностью "М-ЛАЙН" (ООО "М-ЛАЙН") | Device for long-term remote invasive monitoring of state and critical changes of cardiovascular system for patients with comorbidity |
CN108778108A (en) * | 2016-03-23 | 2018-11-09 | 皇家飞利浦有限公司 | Blood pressure monitor |
US11237077B2 (en) | 2018-03-16 | 2022-02-01 | Stmicroelectronics S.R.L. | Stress sensor, structural health monitoring system for constructions and process for manufacturing a stress sensor |
IT201800003693A1 (en) * | 2018-03-16 | 2019-09-16 | St Microelectronics Srl | STRESS SENSOR, STRUCTURAL INTEGRITY MONITORING SYSTEM FOR CONSTRUCTION AND MANUFACTURING PROCESS OF A STRESS SENSOR |
US11898943B2 (en) | 2018-03-16 | 2024-02-13 | Stmicroelectronics S.R.L. | Stress sensor, structural health monitoring system for constructions and process for manufacturing a stress sensor |
Also Published As
Publication number | Publication date |
---|---|
US9498130B2 (en) | 2016-11-22 |
US7686762B1 (en) | 2010-03-30 |
US20090182206A1 (en) | 2009-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7686762B1 (en) | Wireless device and system for monitoring physiologic parameters | |
US7615010B1 (en) | System for monitoring the physiologic parameters of patients with congestive heart failure | |
US7211048B1 (en) | System for monitoring conduit obstruction | |
US8512252B2 (en) | Delivery method and system for monitoring cardiovascular pressures | |
US11033192B2 (en) | Wireless sensor for measuring pressure | |
US6926670B2 (en) | Wireless MEMS capacitive sensor for physiologic parameter measurement | |
US8267863B2 (en) | Procedure and system for monitoring a physiological parameter within an internal organ of a living body | |
JP3149957B2 (en) | Implantable capacitive pressure and temperature sensors | |
US7621036B2 (en) | Method of manufacturing implantable wireless sensor for in vivo pressure measurement | |
US20070282210A1 (en) | Implantable wireless sensor for in vivo pressure measurement and continuous output determination | |
US20090024042A1 (en) | Method and system for monitoring ventricular function of a heart | |
US20040133092A1 (en) | Wireless system for measuring distension in flexible tubes | |
US20080077016A1 (en) | Monitoring system having implantable inductive sensor | |
WO2007002225A2 (en) | Implantable wireless sensor for in vivo pressure measurement | |
WO2008115456A1 (en) | Transseptal monitoring device | |
CN113747835A (en) | Occluder with self-powered sensor | |
US8231538B2 (en) | Perivascular pressure sensor and sensing system | |
US20160183842A1 (en) | Minimally-invasive procedures for monitoring physiological parameters within internal organs and anchors therefor | |
AU2014200072A1 (en) | Implantable wireless sensor for in vivo pressure measurement and continuous output determination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |